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The Inguinal Skin: An Important Site 
of Colonization with Extended-Spectrum 
/3-Lactamase-Producing Enterobacteriaceae 
Extended-spectrum j8-lactamase (ESBL)-producing Entero-
bacteriaceae are spreading and becoming more prevalent 
worldwide.1"3 Once colonized, carriers of ESBL-producing En-
terobacteriaceae carry the strain for prolonged periods and 
may serve as an important source for the spread of ESBL-
producing strains. Unlike for carriers of methicillin-resistant 
Staphylococcus aureus (MRSA),4 for carriers of ESBL-produc-
ing Enterobacteriaceae there is no established decolonization 
regimen available. Screening for ESBL-producing Enterobac-
teriaceae has been performed by using rectal and urine sam-
pling, coupled with throat or wound sampling if clinically 
indicated.5'6 To our knowledge, skin colonization with ESBL-
producing Enterobacteriaceae has never been extensively stud-
ied, because exclusive carriage of ESBL-producing Enterobac-
teriaceae on the skin is considered unlikely. The aim of this 
study was to determine the rate of inguinal colonization in 
carriers of ESBL-producing Enterobacteriaceae. 
The study was performed at the Cantonal Hospital of 
Aarau, Switzerland, a primary and tertiary care center with 
2 intensive care units and 24,000 patients admitted per year. 
During the period from November 2006 through April 2009, 
all newly detected carriers of ESBL-producing Enterobacte-
riaceae gave perianal swab samples, bilateral inguinal swab 
samples, and a urine sample for screening, as required by 
infection control. 
Infection or colonization with ESBL-producing Entero-
bacteriaceae was diagnosed mainly by means of clinical cul-
ture sampling. Six patients were screened for ESBL-producing 
Enterobacteriaceae during a limited outbreak of ESBL-pro-
ducing Klebsiella pneumoniae in the intensive care unit that 
involved 14 individuals. The guidelines of the Clinical and 
Laboratory Standards Institute were used for microbiological 
detection of ESBL production. From November 2006 through 
June 2008, routine susceptibility testing was performed with 
microbroth dilution (Micronaut-S; Merlin), and the follow-
ing antibiotics were used for screening: cefpodoxime, ceftriax-
one, and ceftazidime. Since July 2008, a chromogenic me-
dium (chromID ESBL; bioMerieux) has been used for rapid 
identification of ESBL production. If the screening test yield-
ed positive results, confirmation testing was performed with 
Etest strips containing cefotaxime or ceftazidime, each tested 
with and without clavulanic acid. 
During the study period, 75 carriers of ESBL-producing En-
terobacteriaceae with a median age of 62 years (range, 18-88 
years) were identified. Thirty-seven (49%) patients were men, 
and 57 (76%) patients were hospitalized at the time of diagnosis 
as ESBL carriers; 21 (37%) of the 57 hospitalized patients were 
in the intensive care unit. Escherichia coli (43 [54%] of 79 
strains) and K. pneumoniae (34 [43%] of 79 strains) were the 
most common ESBL-producing organisms, and 4 patients were 
colonized with 2 different strains of ESBL-producing Entero-
bacteriaceae. Results from screening of inguinal, perianal, and 
urine samples were available for 57 (76%), 60 (80%), and 65 
(87%) of the 75 colonized individuals, respectively. Inguinal 
colonization was found in 36 (63%) of 57 patients, perianal 
colonization in 42 (70%) of 60 patients, and urine colonization 
in 47 (72%) of 65 patients. Inguinal colonization was signif-
icantly more common in hospitalized patients than in out-
patients (73% vs 27%; odds ratio, 7.33 [95% confidence in-
terval, 1.41-42.72]; P = .01). In 1 patient only the inguina 
were colonized. Results from screening of perianal and urine 
samples showed only limited correlation with results from 
screening of inguinal samples (Table 1). 
Our findings indicate that the skin is an important site of 
colonization in patients infected or colonized with ESBL-
producing Enterobacteriaceae. Clinical trials are ongoing in 
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TABLE i. Results from Screening Perianal, Inguinal, and Urine 
Samples for Extended-Spectrum /3-Lactamase (ESBL)-Producing 
Enterobacteriaceae 
No. (%) 
Site and colonization status of patients 
Perianal, positive (n = 60) 42 (70) 
Inguinal, positive (« = 57) 36 (63) 
Urine, positive (« = 65) 47 (72) 
Inguinal, positive; perianal, negative (n = 56 ) 7 (12) 
Inguinal, positive; urine, negative (n = 51) 10 (20) 
Inguinal, negative; urine, positive (n = 51) 13 (25) 
an attempt to decolonize carriers of ESBL-producing Enter-
obacteriaceae. However, treatment of the skin is not part of 
such studies (S. Harbath, written communication, 2009). Pre-
viously attempted decolonization methods, including gut and 
urinary decontamination with systemic antibiotics, have been 
of limited efficacy.7'8 Results could probably be improved if 
skin decolonization were included in the decolonization reg-
imens. As with MRSA colonization, failure to identify an im-
portant site of colonization could result in decolonization fail-
ure. In a recent study, a new decolonization regimen includ-
ing antibiotics and application of topical antimicrobial agents 
for throat carriage showed promising results in a subgroup 
of patients.5 On the basis of our findings, future decoloni-
zation attempts should also include treatment of skin colo-
nization with antiseptic soaps. In summary, skin colonization 
was common in carriers of ESBL-producing Enterobacteri-
aceae and may be important for nosocomial transmission of 
these pathogens. 
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